Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Urinary Biomarkers of OI Pathobiology

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
リンクがクリップボードに保存されます
状態アクティブ、募集していない
スポンサー
Baylor College of Medicine
共同編集者
Shriners Hospitals for Children
University of Nebraska
University of Washington

キーワード

概要

Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may have other problems, including hearing loss, dental problems, pain and difficulty getting around. Before the genetic cause of OI was known, OI was classified into four types. Each type was based upon the symptoms and severity of OI. In most people with OI, the cause is a change in one of the genes that makes a protein called type 1 collagen. Some doctors now classify OI both on how severe it is as well as which gene is causing OI. When people classify OI this way, there are more than 10 types of OI. The current laboratory testing to determine OI subtype involves the collection of blood and/or skin cells.

説明

Osteogenesis Imperfecta (OI) is a rare disorder that causes bones to break easily. People with OI may have broken bones with little or no trauma, dentinogenesis imperfecta (DI), and, in adult years, hearing loss. It is seen in both genders and all races. OI can range from very severe to very mild. Individuals with the most severe type of OI may die at birth. People with severe OI who survive may have bowed arms and legs, very short stature and be unable to walk. People with the mildest form of OI may only break bones occasionally and have normal height and lifespan. Breaks can occur in any bone, but are most common in the arms and legs. People with OI also often have problems with the spine. The spine problems include compression fractures and scoliosis (a curvature of the spine). DI is characterized by grey or brown teeth that may chip and wear down and break easily. In addition to weak teeth, the teeth in the upper jaw may not match up with the teeth in the lower jaw.

Before the genetic cause of OI was known, OI was classified into four types. Each type was based upon the symptoms and severity of OI. In most people with OI, the cause is a change in one of the genes that makes a protein called type 1 collagen. In the past decade, it was discovered that in about 5% of people with OI it is in another gene. Some doctors now classify OI both on how severe it is as well as which gene is causing OI. When people classify OI this way, there are more than 10 types of OI. The current laboratory testing to determine OI subtype involves the collection of blood and/or skin cells.

日付

最終確認済み: 03/31/2020
最初に提出された: 08/19/2015
提出された推定登録数: 08/20/2015
最初の投稿: 08/23/2015
最終更新が送信されました: 04/06/2020
最終更新日: 04/07/2020
実際の研究開始日: 08/31/2015
一次完了予定日: 12/31/2019
研究完了予定日: 11/30/2020

状態または病気

Osteogenesis Imperfecta

段階

-

アームグループ

介入/治療
Individuals with OI
Individuals with OI with confirmed specific genetic mutations
Controls/Unaffected
Individuals who do not have OI and who are not related to an individual with OI

適格基準

研究に適格な性別All
サンプリング方法Non-Probability Sample
健康なボランティアを受け入れるはい
基準

Inclusion Criteria:

- To be able to participate, you must:

Be enrolled in The Longitudinal Study of OI (NTC #02432625) and have one of the following genetic mutations:

- glycine substitution mutations in COL1A1 or COL1A2

- haploinsufficient mutation in COL1A1 or COL1A2

- mutations in CRTAP, PPIB, or LEPRE1

- mutations in FKBP10 or SERPINH1

- mutations in (SERPINF1, WNT1, or IFITM5)

- dominant negative glycine substitutions and haploinsufficient mutations in COL1A1, and COL1A2

If you are serving as a control, you must not be related to an individual with OI.

Exclusion Criteria:

- You cannot participate if:

- You are unable to comply with the sample collection schedule.

- You are related to one of the OI subjects and would like to serve as a control subject.

- You have vertebral instrumentation or spinal deformities where we cannot assess lumbar spine aBMD.

- You have a history of recent fracture (< 3 months).

- You have serum creatinine above 1x upper limits of normal.

- You have abnormal kidney function.

- You are using Minoxidil.

- You are unable to provide a urine sample readily.

結果

主な結果の測定

1. HP/LP Ratio [5 Years]

The endpoint will be to compare the HP/LP ratio in OI patients with collagen overmodification (dominant negative mutations in COL1A1, COL1A2, and biallelic mutations in CRTAP, LEPRE1, PPIB) to those without overmodification (FKBP10, SERPINH1, IFITM5, SERPINF1, WNT1, and haploinsufficient mutations in COL1A1 and COL1A2).

二次的な結果の測定

1. HP/LP ratio [5 Years]

The endpoint would be the HP/LP ratio in those with dominant negative type I collagen mutations vs. those with mutations in P3H complex.

Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge